Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 68 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SV Clear all

Conditions: Breast Cancer, Breast Tumor, Cancer of Breast, Cancer of the Breast, Malignant Tumor of Breast, Tumors, Breast
Interventions: BC1 cell line, Bria-OTS regimen and CPI (tislelizumab), Bria-OTS regimen and CPI (tislelizumab) expansion cohort; Biological
Lead sponsor: BriaCell Therapeutics Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Complications; Cesarean Section, Anesthesia; Adverse Effect, Spinal and Epidural
Interventions: experimental, Control; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infection
Interventions: Rifampicin 600 mg; Drug
Lead sponsor: Drexel University; Other
Eligibility: 21 Years to 45 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypoplastic Left Heart Syndrome
Interventions: Magnetic Resonance Imaging, Neurodevelopmental Testing; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 3 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sexual Violence, Behavior Change, Military Training
Interventions: Peer-Based Motivational Interview, Health and Well-Being for All; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 24 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Breastcancer, Breast Neoplasm
Interventions: SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b; Biological · Drug
Lead sponsor: BriaCell Therapeutics Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Santa Rosa, California • Plantation, Florida • Wichita, Kansas + 2 more

Conditions: Smoking Cessation, Tobacco Dependence
Interventions: Varenicline, Counseling and Support Materials, Laboratory Assessments; Drug · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Cognitive Change
Interventions: C1 - Standard Perceptual Learning (SPL), C2 - Long Training (LT), C3 - Short Staircases (SS), C4 - Mixed Difficulty (MD), C5 - Noise Training (NT), C6 - Training with Flankers (TWF), C7 - Parafoveal Training (PT), C8 - Stimulus Variety (SV), C8a - Complex Features (CF), C9 - Exogenous Attention Training (ExAT), C10 - Endogenous Attention Training (EnAT), C11 - Multisensory Facilitation (MF), No Contact Control; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Riverside, California • Boston, Massachusetts • Madison, Wisconsin

Conditions: Sexual Violence, Bystander Intervention
Interventions: Safe Bars active bystander training; Behavioral
Lead sponsor: RTI International; Other
Eligibility: 18 Years and older
Enrollment: 3,180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: Little Rock, Arkansas • Gainesville, Florida • Durham, North Carolina

Conditions: Sepsis, Hypotension
Interventions: Treatment Starling SV monitor; Device
Lead sponsor: Cheetah Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 11
States / cities: San Francisco, California • Denver, Colorado • Atlanta, Georgia + 7 more

Conditions: Non-small Cell Lung Cancer
Interventions: Selected Vegetable and Herb Mix; Drug
Lead sponsor: Sun Farm Corporation; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Sepsis, Hypotension, Septic Shock
Interventions: NICOM; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: HIV Infections
Interventions: Cabotegravir (CAB) tablet, Rilpivirine (RPV) tablet, Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine - Injectable Suspension (RPV LA), ABC/DTG/3TC STR - Tablet, DTG Tablet; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 631 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2029
U.S. locations: 25
States / cities: Birmingham, Alabama • Bakersfield, California • Long Beach, California + 21 more

Conditions: Sepsis, Septic Shock
Interventions: Non-Invasive Cardiac Output Monitoring (NICOM); Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Leukemia, Lymphoma, Paraproteinemias, Multiple Myeloma, Myelodysplastic Syndromes
Interventions: USCOM scan, Fluid Bolus; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Alcohol Use, Unspecified, Sexual Violence, Sexual Assault
Interventions: sexual violence and alcohol use harm reduction text message content, alcohol use reduction content; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 24 Years
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Topical Anesthetic Applied With Sonophoresis
Interventions: DASD Group, Sonic Vibration (SV); Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Knee Osteoarthritis
Interventions: MPPA, SV; Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 35 Years to 85 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Prostate Cancer - Recurrent
Interventions: HDR Brachytherapy + EBRT + STAD; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Single-ventricle
Interventions: Spironolactone; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 1 Year to 6 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Small Intestinal Bacterial Overgrowth, Gastrointestinal Disease, Gastrointestinal Infection
Interventions: AEMCOLO (Rifamycin SV MMX); Drug
Lead sponsor: Bradley Connor; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Peripheral Arterial Disease
Interventions: Atherectomy; Device
Lead sponsor: Avinger, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Grand Rapids, Michigan • Saint Clair Shores, Michigan

Conditions: Hemodynamic Monitoring
Interventions: Starling; Device
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 95 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Prostate Cancer
Interventions: Radiation, Radical Prostatectomy; Radiation · Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 2
States / cities: Durham, North Carolina • Richmond, Virginia

Search by objective public record fields.

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Non-invasive Cardiac Output Monitoring in Obstetric Patients

Immune Activation and Drug Absorption in HIV-Infected Patients

Cerebral Anatomy, Hemodynamics and Metabolism

Collaborative Opportunities for Reducing Alcohol and Sexual Violence Together

SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer

Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence

Moderators and Mediators of Perceptual Learning

Safer Drinking Spaces Study

Fluid Responsiveness Evaluation in Sepsis-associated Hypotension

Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer

Non-Invasive Cardiac Output Monitor (NICOM) for Goal-directed Fluid Resuscitation for Inpatients With Hypotension and/or Septic Shock

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Personalized Fluid Resuscitation in the Emergency Department: A Pilot Trial

Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

Text Message Intervention for Alcohol Use and Sexual Violence in College Students

The Effect of Sonophoresis on Topical Anesthesia: A Pilot Study

Minimally Invasive Knee Replacement Outcomes (MIKRO) Study

HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer

Fibrosis and the Fontan

Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Assessment of the Utility of the Pantheris Small Vessel (SV) System

Starling/CRRT Observational Study

Preoperative Radiation Therapy for High Risk Prostate Cancer